van Hellemond, Irene E. G.
,
Smorenburg, Carolien H.
Peer, Petronella G. M.
Swinkels, Astrid C. P.
Seynaeve, Caroline M.
van der Sangen, Maurice J. C.
Kroep, Judith R.
de Graaf, Hiltje
Honkoop, Aafke H.
Erdkamp, Frans L. G.
van den Berkmortel, Franchette W. P. J.
de Roos, Wilfred K.
Linn, Sabine C.
Imholz, Alexander L. T.
de Boer, Maaike
Tjan-Heijnen, Vivianne C. G. http://orcid.org/0000-0002-3935-7440
Funding for this research was provided by:
AstraZeneca (NCT00301457)
Article History
Received: 29 October 2019
Accepted: 3 February 2020
First Online: 2 March 2020
Compliance with ethical standards
:
: IEGvH, SCL and ACPS report institutional grants from AstraZeneca during the conduct of the study. MdB reports research grants from Roche, Eisai, Novartis, Pfizer, and Lily during the conduct of the study; and consultation/speakers fee from Roche, Novartis, and Pfizer. VCGT-H reports consultant/advisory role to Pfizer, Lily, and Novartis, and grants to the institute for research from AstraZeneca, Roche, Novartis, Pfizer, and Lilly during the conduct of the study. FWPJvdB, FLGE, HdG, AH, ALTI, JRK, PGMP, WKdR, MJCvdS, CMS, CHS declare no conflicts of interests.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.